Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - CASH & EQUIVALENTS
Cash & Equivalents AKBA - Akebia Therapeutics, Inc.
42.9 M
LAST VALUE
-46.47%
2 YEAR CAGR
-16.32%
5 YEAR CAGR
7.30%
10 YEAR CAGR